Free Trial

American Healthcare REIT (AHR) Financials

American Healthcare REIT logo
$34.95 +0.62 (+1.81%)
Closing price 05/27/2025 03:59 PM Eastern
Extended Trading
$34.17 -0.78 (-2.22%)
As of 05/27/2025 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for American Healthcare REIT

Annual Income Statements for American Healthcare REIT

This table shows American Healthcare REIT's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Net Income / (Loss) Attributable to Common Shareholders
-38 -71 -81 -48
Consolidated Net Income / (Loss)
-36 -77 -73 -53
Net Income / (Loss) Continuing Operations
-36 -77 -73 -53
Total Pre-Tax Income
-34 -76 -73 -52
Total Operating Income
84 47 28 21
Total Gross Profit
417 364 362 252
Total Revenue
2,071 1,867 1,643 1,282
Operating Revenue
2,071 1,867 1,643 1,282
Total Cost of Revenue
1,654 1,502 1,282 1,030
Operating Cost of Revenue
1,654 1,502 1,282 1,030
Total Operating Expenses
333 317 334 231
Selling, General & Admin Expense
48 48 43 43
Depreciation Expense
179 183 168 133
Other Operating Expenses / (Income)
53 57 60 39
Impairment Charge
46 24 78 3.34
Restructuring Charge
7.14 5.80 4.39 13
Other Special Charges / (Income)
0.00 -0.73 -20 0.00
Total Other Income / (Expense), net
-118 -123 -101 -73
Interest Expense
128 163 106 81
Interest & Investment Income
4.49 5.88 4.47 0.50
Other Income / (Expense), net
5.47 34 0.78 7.54
Income Tax Expense
1.71 0.66 0.59 0.96
Net Income / (Loss) Attributable to Noncontrolling Interest
2.21 -5.42 7.92 -5.48
Basic Earnings per Share
($0.29) ($1.08) ($1.24) ($0.95)
Weighted Average Basic Shares Outstanding
130.64M 66.05M 65.81M 50.08M
Diluted Earnings per Share
($0.29) ($1.08) ($1.24) ($0.95)
Weighted Average Diluted Shares Outstanding
130.64M 66.05M 65.81M 50.08M
Weighted Average Basic & Diluted Shares Outstanding
157.57M 65.37M - -
Cash Dividends to Common per Share
$1.00 $1.00 $1.60 $0.69

Quarterly Income Statements for American Healthcare REIT

This table shows American Healthcare REIT's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
-32 -4.13 1.98 -3.89 -27 -5.99 -12 -26 - -14
Consolidated Net Income / (Loss)
-32 -3.09 2.93 -3.00 -31 -6.45 -12 -28 - -7.64
Net Income / (Loss) Continuing Operations
-32 -3.09 2.93 -3.00 -31 -6.45 -12 -28 - -7.64
Total Pre-Tax Income
-32 -2.83 3.61 -2.73 -31 -6.16 -12 -27 - -7.52
Total Operating Income
-6.41 34 32 25 14 0.91 23 9.56 - 21
Total Gross Profit
112 107 102 96 98 90 95 82 - 89
Total Revenue
543 524 505 500 483 464 468 452 - 426
Operating Revenue
543 524 505 500 483 464 468 452 - 426
Total Cost of Revenue
431 417 403 404 385 375 373 370 - 337
Operating Cost of Revenue
431 417 403 404 385 375 373 370 - 337
Total Operating Expenses
119 73 70 71 84 89 72 73 - 67
Selling, General & Admin Expense
12 12 12 12 11 11 12 13 - 9.63
Depreciation Expense
47 44 45 43 44 49 45 45 - 40
Other Operating Expenses / (Income)
13 13 13 14 13 15 15 15 - 15
Restructuring Charge
0.81 3.54 0.02 2.78 3.55 1.02 0.89 0.33 - 0.23
Total Other Income / (Expense), net
-26 -37 -28 -28 -45 -7.08 -35 -37 - -29
Interest Expense
30 30 31 36 41 42 41 39 - 28
Interest & Investment Income
1.74 0.02 2.07 0.66 0.86 1.25 2.48 1.30 - 0.33
Other Income / (Expense), net
3.03 -6.28 0.47 8.25 -4.50 34 3.99 0.68 - -1.58
Income Tax Expense
0.49 0.26 0.69 0.28 -0.11 0.28 0.35 0.14 - 0.13
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.66 1.03 0.95 0.89 -3.53 -0.46 0.32 -1.74 - 5.86
Basic Earnings per Share
($0.23) ($0.03) $0.01 ($0.04) ($0.41) ($0.09) ($0.19) ($0.39) - ($0.21)
Weighted Average Basic Shares Outstanding
130.64M 133.73M 130.53M 104.30M 66.05M 66.05M 66.03M 66.03M 65.81M 65.82M
Diluted Earnings per Share
($0.23) ($0.03) $0.01 ($0.04) ($0.41) ($0.09) ($0.19) ($0.39) - ($0.21)
Weighted Average Diluted Shares Outstanding
130.64M 133.73M 130.69M 104.30M 66.05M 66.05M 66.03M 66.03M 65.81M 65.82M
Weighted Average Basic & Diluted Shares Outstanding
157.57M 153.06M 131.65M 131.65M 65.37M 66.23M - - 0.00 -

Annual Cash Flow Statements for American Healthcare REIT

This table details how cash moves in and out of American Healthcare REIT's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Net Change in Cash & Equivalents
33 -21 -14 -27
Net Cash From Operating Activities
176 99 148 18
Net Cash From Continuing Operating Activities
176 99 148 18
Net Income / (Loss) Continuing Operations
-36 -77 -73 -53
Consolidated Net Income / (Loss)
-36 -77 -73 -53
Depreciation Expense
179 183 168 133
Amortization Expense
42 55 33 24
Non-Cash Adjustments To Reconcile Net Income
60 -7.01 59 -1.32
Changes in Operating Assets and Liabilities, net
-70 -55 -38 -85
Net Cash From Investing Activities
-8.73 9.40 -119 -139
Net Cash From Continuing Investing Activities
-8.73 9.40 -119 -139
Purchase of Property, Plant & Equipment
-152 -145 -145 -80
Acquisitions
-0.24 -13 -19 -1.20
Sale of Property, Plant & Equipment
141 185 48 4.50
Sale and/or Maturity of Investments
30 6.08 0.00 -
Other Investing Activities, net
-28 -23 -3.55 0.00
Net Cash From Financing Activities
-135 -129 -43 94
Net Cash From Continuing Financing Activities
-135 -129 -43 94
Repayment of Debt
-1,953 -566 -1,241 -196
Repurchase of Preferred Equity
-36 - - -8.93
Repurchase of Common Equity
-73 -1.96 -23 -0.39
Payment of Dividends
-125 -86 -67 -39
Issuance of Debt
954 562 1,280 350
Issuance of Common Equity
1,364 0.00 0.00 -
Other Financing Activities, net
-267 -36 7.04 -11
Cash Interest Paid
116 153 89 70
Cash Income Taxes Paid
1.32 1.30 1.13 1.24

Quarterly Cash Flow Statements for American Healthcare REIT

This table details how cash moves in and out of American Healthcare REIT's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
6.73 19 -27 34 8.58 -11 5.51 -24 -13 -
Net Cash From Operating Activities
60 63 59 -5.95 26 29 20 24 34 -
Net Cash From Continuing Operating Activities
60 63 59 -5.95 26 29 20 24 34 -
Net Income / (Loss) Continuing Operations
-32 -3.09 2.93 -3.00 -31 -6.45 -12 -28 -49 -
Consolidated Net Income / (Loss)
-32 -3.09 2.93 -3.00 -31 -6.45 -12 -28 -49 -
Depreciation Expense
47 44 45 43 44 49 45 45 45 -
Amortization Expense
10 9.65 11 12 8.12 14 12 20 11 -
Non-Cash Adjustments To Reconcile Net Income
53 1.54 3.46 1.46 8.73 -16 1.71 -1.37 33 -
Changes in Operating Assets and Liabilities, net
-18 11 -3.09 -59 -4.07 -12 -27 -12 -5.93 -
Net Cash From Investing Activities
87 -30 -60 -5.22 -11 11 43 -33 3.96 -
Net Cash From Continuing Investing Activities
87 -30 -60 -5.22 -11 11 43 -33 3.96 -
Purchase of Property, Plant & Equipment
-38 -30 -65 -20 -25 -55 -31 -33 -18 -
Acquisitions
-0.24 - - 0.00 -0.59 - -6.00 -6.34 -0.42 -
Sale of Property, Plant & Equipment
127 0.01 -0.00 15 17 80 81 6.90 23 -
Sale and/or Maturity of Investments
6.45 4.40 11 8.38 6.08 - - 0.00 - -
Other Investing Activities, net
-7.82 -5.26 -6.64 -7.89 -8.06 -14 -0.31 -0.71 -0.03 -
Net Cash From Financing Activities
-140 -14 -26 45 -5.89 -52 -57 -14 -51 -
Net Cash From Continuing Financing Activities
-140 -14 -26 45 -5.89 -52 -57 -14 -51 -
Repayment of Debt
-538 -339 -277 -799 -160 -150 -168 -88 -168 -
Repurchase of Common Equity
33 -57 -1.94 -48 15 -16 -0.87 -0.08 -5.88 -
Payment of Dividends
-39 -34 -34 -18 -18 -18 -20 -31 -20 -
Issuance of Debt
325 168 299 163 158 143 139 121 122 -
Issuance of Common Equity
120 471 - 773 - - - 0.00 - -
Other Financing Activities, net
-5.14 -223 -37 -0.73 -1.54 -27 -7.03 -0.88 20 -
Cash Interest Paid
25 28 27 36 39 38 39 37 28 -
Cash Income Taxes Paid
0.43 0.16 0.58 0.16 0.28 0.22 0.41 0.38 0.48 -

Annual Balance Sheets for American Healthcare REIT

This table presents American Healthcare REIT's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Total Assets
4,488 4,578 4,787
Total Current Assets
288 229 203
Cash & Equivalents
77 43 65
Accounts Receivable
211 185 138
Plant, Property, & Equipment, net
3,367 3,425 3,582
Total Noncurrent Assets
834 924 1,003
Goodwill
235 235 232
Intangible Assets
161 180 236
Other Noncurrent Operating Assets
437 508 535
Total Liabilities & Shareholders' Equity
4,488 4,578 4,787
Total Liabilities
2,184 3,119 3,137
Total Current Liabilities
258 243 244
Accounts Payable
258 243 244
Total Noncurrent Liabilities
1,926 2,876 2,894
Long-Term Debt
1,671 2,526 2,512
Capital Lease Obligations
165 226 273
Noncurrent Deferred Revenue
52 76 50
Other Noncurrent Operating Liabilities
38 48 59
Commitments & Contingencies
0.00 0.00 0.00
Redeemable Noncontrolling Interest
0.22 34 82
Total Equity & Noncontrolling Interests
2,304 1,425 1,568
Total Preferred & Common Equity
2,261 1,270 1,400
Preferred Stock
0.00 0.00 0.00
Total Common Equity
2,261 1,270 1,400
Common Stock
3,722 2,549 2,541
Retained Earnings
-1,458 -1,276 -1,138
Accumulated Other Comprehensive Income / (Loss)
-2.51 -2.43 -2.69
Noncontrolling Interest
43 155 168

Quarterly Balance Sheets for American Healthcare REIT

This table presents American Healthcare REIT's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023
Total Assets
4,677 4,645 4,703 4,589
Total Current Assets
272 253 293 205
Cash & Equivalents
68 52 77 35
Accounts Receivable
204 201 216 169
Plant, Property, & Equipment, net
3,536 3,510 3,479 0.00
Total Noncurrent Assets
870 882 932 4,384
Goodwill
235 235 235 235
Intangible Assets
178 179 188 197
Other Noncurrent Operating Assets
457 468 509 3,952
Total Liabilities & Shareholders' Equity
4,677 4,645 4,703 4,589
Total Liabilities
2,420 2,541 2,561 3,055
Total Current Liabilities
270 254 257 234
Accounts Payable
270 254 257 234
Total Noncurrent Liabilities
2,150 2,287 2,303 2,821
Long-Term Debt
1,879 2,012 1,988 2,498
Capital Lease Obligations
174 179 220 -
Noncurrent Deferred Revenue
52 50 49 44
Other Noncurrent Operating Liabilities
45 46 47 279
Commitments & Contingencies
0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
0.22 0.22 12 60
Total Equity & Noncontrolling Interests
2,257 2,104 2,131 1,474
Total Preferred & Common Equity
2,207 1,933 1,961 1,314
Preferred Stock
0.00 0.00 0.00 0.00
Total Common Equity
2,207 1,933 1,961 1,314
Common Stock
3,596 3,280 3,277 2,549
Retained Earnings
-1,387 -1,344 -1,313 -1,232
Accumulated Other Comprehensive Income / (Loss)
-2.15 -2.46 -2.47 -2.62
Noncontrolling Interest
49 171 170 159

Annual Metrics And Ratios for American Healthcare REIT

This table displays calculated financial ratios and metrics derived from American Healthcare REIT's official financial filings.

Metric 2024 2023 2022 2021
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Growth Metrics
- - - -
Revenue Growth
10.93% 13.60% 28.15% 0.00%
EBITDA Growth
-2.32% 38.86% 23.60% 0.00%
EBIT Growth
10.20% 182.64% 2.00% 0.00%
NOPAT Growth
77.61% 69.21% 35.57% 0.00%
Net Income Growth
53.70% -4.77% -37.76% 0.00%
EPS Growth
73.15% 12.90% -30.53% 0.00%
Operating Cash Flow Growth
78.71% -33.32% 724.92% 0.00%
Free Cash Flow Firm Growth
-30.48% 105.39% 0.00% 0.00%
Invested Capital Growth
-2.50% -4.61% 0.00% 0.00%
Revenue Q/Q Growth
2.99% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
-2.40% 31.68% 0.00% 0.00%
EBIT Q/Q Growth
-12.39% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
-19.38% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
-4.31% 0.00% 0.00% 0.00%
EPS Q/Q Growth
38.30% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
23.70% -7.99% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
194.38% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
-4.22% 4.27% 0.00% 0.00%
Profitability Metrics
- - - -
Gross Margin
20.13% 19.52% 22.01% 19.66%
EBITDA Margin
15.02% 17.06% 13.95% 14.47%
Operating Margin
4.05% 2.53% 1.70% 1.61%
EBIT Margin
4.32% 4.34% 1.75% 2.19%
Profit (Net Income) Margin
-1.72% -4.12% -4.47% -4.15%
Tax Burden Percent
105.06% 100.87% 100.81% 101.83%
Interest Burden Percent
-37.92% -94.01% -253.75% -186.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
1.43% 0.77% 0.89% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-2.80% -3.28% -5.94% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-3.32% -5.72% -9.79% 0.00%
Return on Equity (ROE)
-1.89% -4.95% -8.90% 0.00%
Cash Return on Invested Capital (CROIC)
3.96% 5.49% -199.11% 0.00%
Operating Return on Assets (OROA)
1.97% 1.73% 1.20% 0.00%
Return on Assets (ROA)
-0.79% -1.64% -3.07% 0.00%
Return on Common Equity (ROCE)
-1.78% -4.25% -7.55% 0.00%
Return on Equity Simple (ROE_SIMPLE)
-1.57% -6.05% -5.24% 0.00%
Net Operating Profit after Tax (NOPAT)
59 33 20 14
NOPAT Margin
2.84% 1.77% 1.19% 1.12%
Net Nonoperating Expense Percent (NNEP)
4.22% 4.05% 6.83% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
1.42% 0.79% 0.45% -
Cost of Revenue to Revenue
79.87% 80.48% 77.99% 80.34%
SG&A Expenses to Revenue
2.30% 2.55% 2.64% 3.37%
R&D to Revenue
0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
16.08% 16.99% 20.31% 18.05%
Earnings before Interest and Taxes (EBIT)
89 81 29 28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
311 318 229 186
Valuation Ratios
- - - -
Price to Book Value (P/BV)
1.92 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
2.33 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.10 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00
Dividend Yield
3.52% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.51 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
2.97 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
19.78 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
68.85 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
104.77 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
34.94 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
37.74 0.00 0.00 0.00
Leverage & Solvency
- - - -
Debt to Equity
0.80 1.89 1.69 0.00
Long-Term Debt to Equity
0.80 1.89 1.69 0.00
Financial Leverage
1.19 1.75 1.65 0.00
Leverage Ratio
2.41 3.01 2.90 0.00
Compound Leverage Factor
-0.91 -2.83 -7.36 0.00
Debt to Total Capital
44.34% 65.35% 62.80% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
44.34% 65.35% 62.80% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.04% 4.48% 5.62% 0.00%
Common Equity to Total Capital
54.62% 30.17% 31.58% 0.00%
Debt to EBITDA
5.90 8.64 12.15 0.00
Net Debt to EBITDA
5.66 8.51 11.86 0.00
Long-Term Debt to EBITDA
5.90 8.64 12.15 0.00
Debt to NOPAT
31.26 83.23 142.52 0.00
Net Debt to NOPAT
29.96 81.92 139.19 0.00
Long-Term Debt to NOPAT
31.26 83.23 142.52 0.00
Altman Z-Score
1.28 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
6.16% 14.09% 15.11% 0.00%
Liquidity Ratios
- - - -
Current Ratio
1.11 0.94 0.83 0.00
Quick Ratio
1.11 0.94 0.83 0.00
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
163 234 -4,349 0.00
Operating Cash Flow to CapEx
1,597.89% 0.00% 153.20% 23.82%
Free Cash Flow to Firm to Interest Expense
1.28 1.44 -41.05 0.00
Operating Cash Flow to Interest Expense
1.38 0.60 1.39 0.22
Operating Cash Flow Less CapEx to Interest Expense
1.29 0.85 0.48 -0.71
Efficiency Ratios
- - - -
Asset Turnover
0.46 0.40 0.69 0.00
Accounts Receivable Turnover
10.45 11.56 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.61 0.53 0.00 0.00
Accounts Payable Turnover
6.60 6.17 0.00 0.00
Days Sales Outstanding (DSO)
34.94 31.57 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
55.31 59.13 0.00 0.00
Cash Conversion Cycle (CCC)
-20.36 -27.56 0.00 0.00
Capital & Investment Metrics
- - - -
Invested Capital
4,063 4,168 4,369 0.00
Invested Capital Turnover
0.50 0.44 0.75 0.00
Increase / (Decrease) in Invested Capital
-104 -201 4,369 0.00
Enterprise Value (EV)
6,152 0.00 0.00 0.00
Market Capitalization
4,350 0.00 0.00 0.00
Book Value per Share
$14.77 $19.18 $21.28 $0.00
Tangible Book Value per Share
$12.18 $12.91 $14.17 $0.00
Total Capital
4,140 4,211 4,434 0.00
Total Debt
1,836 2,752 2,785 0.00
Total Long-Term Debt
1,836 2,752 2,785 0.00
Net Debt
1,759 2,708 2,720 0.00
Capital Expenditures (CapEx)
11 -39 96 75
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-47 -58 -106 0.00
Debt-free Net Working Capital (DFNWC)
29 -14 -41 0.00
Net Working Capital (NWC)
29 -14 -41 0.00
Net Nonoperating Expense (NNE)
94 110 93 68
Net Nonoperating Obligations (NNO)
1,759 2,708 2,720 0.00
Total Depreciation and Amortization (D&A)
222 237 201 157
Debt-free, Cash-free Net Working Capital to Revenue
-2.28% -3.08% -6.47% 0.00%
Debt-free Net Working Capital to Revenue
1.42% -0.75% -2.51% 0.00%
Net Working Capital to Revenue
1.42% -0.75% -2.51% 0.00%
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
($0.29) ($1.08) $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
130.64M 66.05M 0.00 0.00
Adjusted Diluted Earnings per Share
($0.29) ($1.08) $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
130.64M 66.05M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
157.57M 65.37M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
96 54 63 26
Normalized NOPAT Margin
4.62% 2.88% 3.86% 2.02%
Pre Tax Income Margin
-1.64% -4.08% -4.43% -4.08%
Debt Service Ratios
- - - -
EBIT to Interest Expense
0.70 0.50 0.27 0.35
NOPAT to Interest Expense
0.46 0.20 0.18 0.18
EBIT Less CapEx to Interest Expense
0.61 0.74 -0.64 -0.58
NOPAT Less CapEx to Interest Expense
0.37 0.44 -0.73 -0.75
Payout Ratios
- - - -
Dividend Payout Ratio
-349.76% -112.36% -91.29% -73.49%
Augmented Payout Ratio
-554.07% -114.90% -122.34% -74.22%

Quarterly Metrics And Ratios for American Healthcare REIT

This table displays calculated financial ratios and metrics derived from American Healthcare REIT's official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - -
Revenue Growth
12.47% 12.83% 7.92% 10.46% 0.00% 8.94% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth
-12.48% -16.71% 5.09% 16.40% 8.43% 62.72% 0.00% 0.00% 0.00% 0.00%
EBIT Growth
-136.54% -20.36% 19.05% 222.89% 0.00% 75.78% 0.00% 0.00% 0.00% 0.00%
NOPAT Growth
-146.62% 3,601.53% 59.30% 159.52% 0.00% -95.70% 0.00% 0.00% 0.00% 0.00%
Net Income Growth
-4.75% 52.02% 124.66% 89.12% 0.00% 15.67% 0.00% 0.00% 0.00% 0.00%
EPS Growth
43.90% 66.67% 105.26% 89.74% 0.00% 57.14% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
130.93% 116.76% 200.31% -124.95% -24.93% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Growth
-52.71% 94.45% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth
-2.50% 6.14% 0.00% 0.00% -4.61% 0.00% 0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth
3.61% 3.81% 1.01% 3.51% 3.95% -0.71% 3.39% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
-34.10% -7.70% 0.72% 42.85% -37.28% 16.46% 11.55% 33.07% -5.88% 0.00%
EBIT Q/Q Growth
-112.28% -14.27% -2.77% 256.99% -73.23% 28.15% 163.70% 0.00% -100.00% 0.00%
NOPAT Q/Q Growth
-118.95% -7.69% 47.78% 80.30% 1,404.92% -96.03% 140.75% 0.00% -100.00% 0.00%
Net Income Q/Q Growth
-948.46% -205.71% 197.40% 90.30% -380.28% 45.68% 57.03% 0.00% 0.00% 0.00%
EPS Q/Q Growth
-666.67% -400.00% 125.00% 90.24% -355.56% 52.63% 51.28% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
-5.74% 6.28% 1,097.68% -123.11% -11.52% 47.24% -17.11% -30.49% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
144.98% 94.74% 0.90% -2,116.48% 105.28% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
-4.22% -0.02% -0.71% 2.54% 4.27% 0.00% 0.00% -100.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - -
Gross Margin
20.67% 20.37% 20.22% 19.20% 20.22% 19.31% 20.32% 18.15% 0.00% 20.81%
EBITDA Margin
9.89% 15.55% 17.49% 17.54% 12.71% 21.07% 17.96% 16.65% 0.00% 14.10%
Operating Margin
-1.18% 6.46% 6.28% 4.96% 2.85% 0.20% 4.92% 2.11% 0.00% 4.99%
EBIT Margin
-0.62% 5.26% 6.37% 6.62% 1.92% 7.45% 5.77% 2.26% 0.00% 4.62%
Profit (Net Income) Margin
-5.98% -0.59% 0.58% -0.60% -6.42% -1.39% -2.54% -6.11% 0.00% -1.79%
Tax Burden Percent
101.52% 109.29% 81.01% 110.20% 99.64% 104.61% 103.02% 100.52% 0.00% 101.68%
Interest Burden Percent
944.22% -10.27% 11.24% -8.25% -335.58% -17.81% -42.67% -268.36% 0.00% -38.20%
Effective Tax Rate
0.00% 0.00% 18.99% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-0.42% 2.21% 4.68% 3.11% 0.87% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-1.67% 1.00% 2.55% 1.20% -0.62% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-1.98% 1.18% 2.59% 1.19% -1.09% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-2.39% 3.38% 7.27% 4.31% -0.22% 0.00% 0.00% 0.00% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)
3.96% -4.19% -197.65% -197.95% 5.49% 0.00% 0.00% 0.00% -99.55% 0.00%
Operating Return on Assets (OROA)
-0.28% 2.28% 5.35% 5.39% 0.76% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)
-2.73% -0.26% 0.49% -0.49% -2.56% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
-2.25% 3.14% 6.68% 3.94% -0.18% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)
0.00% -1.55% -1.94% -2.67% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-4.49 24 26 17 9.63 0.64 16 6.69 0.00 15
NOPAT Margin
-0.83% 4.52% 5.08% 3.48% 2.00% 0.14% 3.44% 1.48% 0.00% 3.49%
Net Nonoperating Expense Percent (NNEP)
1.25% 1.20% 2.13% 1.91% 1.50% 0.58% 0.00% 0.00% 0.00% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
-0.11% - - - 0.23% - - - 0.00% -
Cost of Revenue to Revenue
79.33% 79.63% 79.78% 80.80% 79.78% 80.69% 79.68% 81.85% 0.00% 79.19%
SG&A Expenses to Revenue
2.22% 2.28% 2.33% 2.37% 2.35% 2.44% 2.52% 2.89% 0.00% 2.26%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
21.85% 13.91% 13.94% 14.23% 17.37% 19.11% 15.40% 16.04% 0.00% 15.82%
Earnings before Interest and Taxes (EBIT)
-3.38 28 32 33 9.26 35 27 10 0.00 20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
54 81 88 88 61 98 84 75 57 60
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.92 1.56 0.99 0.48 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
2.33 1.91 1.27 0.62 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.10 1.71 0.99 0.50 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
3.52% 2.87% 3.42% 1.72% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.51 1.29 1.00 0.76 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
2.97 2.72 2.17 1.70 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
19.78 17.17 12.64 9.86 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
68.85 53.64 38.82 31.38 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
104.77 75.11 85.01 74.55 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
34.94 38.43 39.07 47.45 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
37.74 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.80 0.91 1.04 1.03 1.89 1.63 0.00 0.00 1.69 0.00
Long-Term Debt to Equity
0.80 0.91 1.04 1.03 1.89 1.63 0.00 0.00 1.69 0.00
Financial Leverage
1.19 1.17 1.02 0.99 1.75 1.61 0.00 0.00 1.65 0.00
Leverage Ratio
2.41 2.44 2.21 2.20 3.01 2.99 0.00 0.00 2.90 0.00
Compound Leverage Factor
22.75 -0.25 0.25 -0.18 -10.11 -0.53 0.00 0.00 0.00 0.00
Debt to Total Capital
44.34% 47.63% 51.01% 50.74% 65.35% 61.96% 0.00% 0.00% 62.80% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
44.34% 47.63% 51.01% 50.74% 65.35% 61.96% 0.00% 0.00% 62.80% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.04% 1.15% 3.98% 4.18% 4.48% 5.44% 0.00% 0.00% 5.62% 0.00%
Common Equity to Total Capital
54.62% 51.22% 45.01% 45.07% 30.17% 32.60% 0.00% 0.00% 31.58% 0.00%
Debt to EBITDA
5.90 6.44 6.54 6.67 8.64 10.33 0.00 0.00 12.15 0.00
Net Debt to EBITDA
5.66 6.23 6.39 6.44 8.51 10.19 0.00 0.00 11.86 0.00
Long-Term Debt to EBITDA
5.90 6.44 6.54 6.67 8.64 10.33 0.00 0.00 12.15 0.00
Debt to NOPAT
31.26 28.19 44.00 50.48 83.23 0.00 0.00 0.00 142.52 0.00
Net Debt to NOPAT
29.96 27.25 42.95 48.72 81.92 0.00 0.00 0.00 139.19 0.00
Long-Term Debt to NOPAT
31.26 28.19 44.00 50.48 83.23 0.00 0.00 0.00 142.52 0.00
Altman Z-Score
1.21 0.89 0.49 0.27 0.00 0.00 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
6.16% 7.10% 8.11% 8.49% 14.09% 14.31% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.11 1.01 1.00 1.14 0.94 0.87 0.00 0.00 0.83 0.00
Quick Ratio
1.11 1.01 1.00 1.14 0.94 0.87 0.00 0.00 0.83 0.00
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
100 -222 -4,217 -4,256 211 -3,996 0.00 0.00 0.00 0.00
Operating Cash Flow to CapEx
0.00% 213.63% 92.00% -104.16% 295.04% 0.00% 0.00% 90.80% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
3.29 -7.30 -137.84 -116.80 5.12 -95.14 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
1.96 2.08 1.94 -0.16 0.63 0.69 0.48 0.61 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
4.90 1.10 -0.17 -0.32 0.41 1.29 1.69 -0.06 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.46 0.43 0.84 0.81 0.40 0.00 0.00 0.00 0.69 0.00
Accounts Receivable Turnover
10.45 10.78 0.00 0.00 11.56 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.61 0.00 0.00 0.00 0.53 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
6.60 6.39 0.00 0.00 6.17 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
34.94 33.87 0.00 0.00 31.57 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
55.31 57.16 0.00 0.00 59.13 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
-20.36 -23.28 0.00 0.00 -27.56 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
4,063 4,242 4,243 4,273 4,168 3,997 0.00 0.00 4,369 0.00
Invested Capital Turnover
0.50 0.49 0.92 0.90 0.44 0.00 0.00 0.00 0.38 0.00
Increase / (Decrease) in Invested Capital
-104 246 4,243 4,273 -201 3,997 0.00 0.00 0.00 0.00
Enterprise Value (EV)
6,152 5,471 4,233 3,260 0.00 0.00 0.00 0.00 0.00 0.00
Market Capitalization
4,350 3,436 1,923 948 0.00 0.00 0.00 0.00 0.00 0.00
Book Value per Share
$14.77 $16.77 $14.69 $30.00 $19.18 $19.90 $0.00 $0.00 $21.28 $0.00
Tangible Book Value per Share
$12.18 $13.63 $11.54 $23.53 $12.91 $13.36 $0.00 $0.00 $14.17 $0.00
Total Capital
4,140 4,310 4,295 4,350 4,211 4,032 0.00 0.00 4,434 0.00
Total Debt
1,836 2,053 2,191 2,208 2,752 2,498 0.00 0.00 2,785 0.00
Total Long-Term Debt
1,836 2,053 2,191 2,208 2,752 2,498 0.00 0.00 2,785 0.00
Net Debt
1,759 1,985 2,139 2,130 2,708 2,463 0.00 0.00 2,720 0.00
Capital Expenditures (CapEx)
-89 30 65 5.72 8.73 -25 -49 26 -4.41 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-47 -66 -53 -41 -58 -64 0.00 0.00 -106 0.00
Debt-free Net Working Capital (DFNWC)
29 1.74 -0.54 36 -14 -29 0.00 0.00 -41 0.00
Net Working Capital (NWC)
29 1.74 -0.54 36 -14 -29 0.00 0.00 -41 0.00
Net Nonoperating Expense (NNE)
28 27 23 20 41 7.09 28 34 0.00 23
Net Nonoperating Obligations (NNO)
1,759 1,985 2,139 2,130 2,708 2,463 0.00 0.00 2,720 0.00
Total Depreciation and Amortization (D&A)
57 54 56 55 52 63 57 65 57 40
Debt-free, Cash-free Net Working Capital to Revenue
-2.28% -3.29% -2.70% -2.16% -3.08% 0.00% 0.00% 0.00% -6.47% 0.00%
Debt-free Net Working Capital to Revenue
1.42% 0.09% -0.03% 1.86% -0.75% 0.00% 0.00% 0.00% -2.51% 0.00%
Net Working Capital to Revenue
1.42% 0.09% -0.03% 1.86% -0.75% 0.00% 0.00% 0.00% -2.51% 0.00%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.23) ($0.03) $0.01 ($0.04) ($0.41) ($0.09) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
130.64M 133.73M 130.53M 104.30M 66.05M 66.05M 0.00 0.00 65.81M 0.00
Adjusted Diluted Earnings per Share
($0.23) ($0.03) $0.01 ($0.04) ($0.41) ($0.09) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
130.64M 133.73M 130.69M 104.30M 66.05M 66.05M 0.00 0.00 65.81M 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
157.57M 153.06M 131.65M 131.65M 65.37M 66.23M 0.00 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
-3.92 26 26 19 12 10 17 6.41 0.00 17
Normalized NOPAT Margin
-0.72% 4.99% 5.09% 3.87% 2.51% 2.18% 3.58% 1.42% 0.00% 3.91%
Pre Tax Income Margin
-5.89% -0.54% 0.72% -0.55% -6.44% -1.33% -2.46% -6.07% 0.00% -1.76%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
-0.11 0.91 1.05 0.91 0.22 0.82 0.66 0.26 0.00 0.72
NOPAT to Interest Expense
-0.15 0.78 0.84 0.48 0.23 0.02 0.39 0.17 0.00 0.54
EBIT Less CapEx to Interest Expense
2.82 -0.07 -1.06 0.75 0.01 1.42 1.86 -0.41 0.00 0.72
NOPAT Less CapEx to Interest Expense
2.78 -0.19 -1.27 0.32 0.02 0.61 1.60 -0.50 0.00 0.54
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
-349.76% -303.75% -232.75% -140.42% -112.36% 0.00% 0.00% 0.00% -91.29% 0.00%
Augmented Payout Ratio
-554.07% -570.25% -367.46% -234.96% -114.90% 0.00% 0.00% 0.00% -122.34% 0.00%

Frequently Asked Questions About American Healthcare REIT's Financials

When does American Healthcare REIT's fiscal year end?

According to the most recent income statement we have on file, American Healthcare REIT's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has American Healthcare REIT's net income changed over the last 3 years?

American Healthcare REIT's net income appears to be on a downward trend, with a most recent value of -$35.60 million in 2024, falling from -$53.27 million in 2021. The previous period was -$76.89 million in 2023. View American Healthcare REIT's forecast to see where analysts expect American Healthcare REIT to go next.

What is American Healthcare REIT's operating income?
American Healthcare REIT's total operating income in 2024 was $83.89 million, based on the following breakdown:
  • Total Gross Profit: $416.78 million
  • Total Operating Expenses: $332.89 million
How has American Healthcare REIT revenue changed over the last 3 years?

Over the last 3 years, American Healthcare REIT's total revenue changed from $1.28 billion in 2021 to $2.07 billion in 2024, a change of 61.5%.

How much debt does American Healthcare REIT have?

American Healthcare REIT's total liabilities were at $2.18 billion at the end of 2024, a 30.0% decrease from 2023, and a 30.4% decrease since 2022.

How much cash does American Healthcare REIT have?

In the past 2 years, American Healthcare REIT's cash and equivalents has ranged from $43.45 million in 2023 to $76.70 million in 2024, and is currently $76.70 million as of their latest financial filing in 2024.

How has American Healthcare REIT's book value per share changed over the last 3 years?

Over the last 3 years, American Healthcare REIT's book value per share changed from 0.00 in 2021 to 14.77 in 2024, a change of 1,477.3%.



This page (NYSE:AHR) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners